<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04137783</url>
  </required_header>
  <id_info>
    <org_study_id>00020191017</org_study_id>
    <nct_id>NCT04137783</nct_id>
  </id_info>
  <brief_title>ABCA3 Gene and RDS in Late Preterm and Term Infants</brief_title>
  <official_title>ABCA3 Gene Mutations in Late Preterm and Term Infants With Fatal Unexplained Respiratory Distress Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital of Chongqing Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Respiratory distress syndrome (RDS) is the most common respiratory cause of mortality and&#xD;
      morbidity in very preterm infants, but it also could be seen in late preterm and term&#xD;
      infants. Some genetic mechanisms were involved in the pathogenesis of RDS in late preterm and&#xD;
      term infants.&#xD;
&#xD;
      ATP-binding cassette transporter A3 (ABCA3) is essential for the production of pulmonary&#xD;
      surfactant, whose mutation is the most common monogenetic cause of RDS in newborns. It also&#xD;
      takes a vital role on unexplained RDS (URDS) in late preterm and term infants. Some previous&#xD;
      studies showed that URDS with homozygous or compound heterozygous ABCA3 mutations had high&#xD;
      mortality, while different mutation types could lead to different outcomes. However, most of&#xD;
      the study focused on URDS with ABCA3 gene mutations, and there is no evidence that URDS&#xD;
      without confirmed gene mutations have relatively better or worse outcomes. Furthermore, all&#xD;
      the population in previous study are non-Asian races, which indicated that all the study&#xD;
      conclusion is not applicable in Asia.&#xD;
&#xD;
      Based on the next-generation sequencing technology, exome sequencing has been widely used in&#xD;
      the clinic. In our neonatal intensive care unit (NICU), a clinic exome sequencing was usually&#xD;
      performed in infants with fatal URDS. The present study was designed to compare the URDS with&#xD;
      ABCA3 gene mutations with those without confirmed gene mutations and to establish the&#xD;
      relationship between various ABCA3 gene mutations and variant RDS severity and outcomes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Actual">December 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>through study completion, an average of 1 month</time_frame>
    <description>the ratio of dead patients against the corresponding group population</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the Onset of Respiratory Distress Syndrome</measure>
    <time_frame>up to 1 week</time_frame>
    <description>the age when the patients presented with respiratory distress sydnrome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the Age of Developing Severe RDS Marked With Oxygenation Index of 16</measure>
    <time_frame>through study of completion, an average of 1 month</time_frame>
    <description>the age when the patients develop severe RDS,which is marked with an oxygenation index of 16</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological Score</measure>
    <time_frame>through study of completion, an average of 1 month</time_frame>
    <description>The chest x-ray was rated in three sections on both sides of the lung: apex to the carina, carina to the lower pulmonary vein, and lower pulmonary vein to diaphragm. The incidence of radiological features, including ground-glass opacity, reticular pattern, air bronchogram, atelectasis, and air leak, was evaluated for each lung section, respectively. Each finding was scored as 0=none, 1=discrete，2=diffuse, and 3= strong at each section. An overall cumulative score was calculated by adding the individual section scores together, making a minimum of 0, and a maximum of 18 for each patient. Higher scores mean the higher severity of the radiological apperance, and commonly predict worse respiratory outcomes.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">39</enrollment>
  <condition>Respiratory Distress Syndrome, Newborn</condition>
  <arm_group>
    <arm_group_label>homozygous or compound heterozygous ABCA3 mutations</arm_group_label>
    <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated homozgyous or compound heterozygous ABCA3 mutations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>single ABCA3 mutation</arm_group_label>
    <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated single mutations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no ABCA3 mutations</arm_group_label>
    <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which exclude all gene mutations involving in the respiratory disease.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>there is no intervention in this study, only observation.</description>
    <arm_group_label>homozygous or compound heterozygous ABCA3 mutations</arm_group_label>
    <arm_group_label>no ABCA3 mutations</arm_group_label>
    <arm_group_label>single ABCA3 mutation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All the infants ≥34 weeks'gestation was admitted in neonatal intensive care unit of&#xD;
        Children's Hospital of Chongqing Medical University from January 2013 to December 2018&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  infants ≥34 weeks' gestation&#xD;
&#xD;
          -  meet the fatal respiratory distress syndrome as following: (1) manifestations and&#xD;
             chest radiograph are compatible with RDS; (2) at least 7days on invasive ventilation&#xD;
             with FiO2 ≥60%, or persistent hypoxemic respiratory failure on FiO2 100% regardless of&#xD;
             duration of invasive ventilation&#xD;
&#xD;
          -  undergone exome sequencing&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  culture-positive sepsis&#xD;
&#xD;
          -  cardiopulmonary malformations&#xD;
&#xD;
          -  pulmonary hypoplasia&#xD;
&#xD;
          -  known surfactant mutations such as SFTPB, SFTPC, CHPT1, LPCAT1 and PCYT1B were&#xD;
             excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wang Jianhui, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Chongqing Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400014</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>October 20, 2019</study_first_submitted>
  <study_first_submitted_qc>October 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 24, 2019</study_first_posted>
  <results_first_submitted>March 26, 2021</results_first_submitted>
  <results_first_submitted_qc>July 15, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">August 6, 2021</results_first_posted>
  <last_update_submitted>July 15, 2021</last_update_submitted>
  <last_update_submitted_qc>July 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital of Chongqing Medical University</investigator_affiliation>
    <investigator_full_name>Wang Jianhui</investigator_full_name>
    <investigator_title>Attending Doctor</investigator_title>
  </responsible_party>
  <keyword>respiratory distress syndrome</keyword>
  <keyword>ABCA3 gene</keyword>
  <keyword>exome sequencing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 16, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/83/NCT04137783/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Homozygous or Compound Heterozygous ABCA3 Mutations</title>
          <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated homozgyous or compound heterozygous ABCA3 mutations.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
        </group>
        <group group_id="P2">
          <title>Single ABCA3 Mutation</title>
          <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated single mutations.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
        </group>
        <group group_id="P3">
          <title>no ABCA3 Mutations</title>
          <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which exclude all gene mutations involving in the respiratory disease.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Homozygous or Compound Heterozygous ABCA3 Mutations</title>
          <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated homozgyous or compound heterozygous ABCA3 mutations.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
        </group>
        <group group_id="B2">
          <title>Single ABCA3 Mutation</title>
          <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated single mutations.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
        </group>
        <group group_id="B3">
          <title>no ABCA3 Mutations</title>
          <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which exclude all gene mutations involving in the respiratory disease.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="7"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="22"/>
            <count group_id="B4" value="39"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Gestational age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.85" spread="2.12"/>
                    <measurement group_id="B2" value="36.80" spread="1.81"/>
                    <measurement group_id="B3" value="37.27" spread="2.27"/>
                    <measurement group_id="B4" value="37.08" spread="2.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Birthweight(grams)</title>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2996.57" spread="351.92"/>
                    <measurement group_id="B2" value="2934.10" spread="517.68"/>
                    <measurement group_id="B3" value="3043.59" spread="358.03"/>
                    <measurement group_id="B4" value="3007.08" spread="395.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cesarean section (n, %)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Resuscitation (n, %)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fetal distress (n, %)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Meconium stained amniotic fluid (n, %)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Maternal history</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>premature rupture of membrane</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>gestational diabetes mellitus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Preeclampsia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mortality</title>
        <description>the ratio of dead patients against the corresponding group population</description>
        <time_frame>through study completion, an average of 1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Homozygous or Compound Heterozygous ABCA3 Mutations</title>
            <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated homozgyous or compound heterozygous ABCA3 mutations.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
          </group>
          <group group_id="O2">
            <title>Single ABCA3 Mutation</title>
            <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated single mutations.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
          </group>
          <group group_id="O3">
            <title>no ABCA3 Mutations</title>
            <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which exclude all gene mutations involving in the respiratory disease.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
          </group>
        </group_list>
        <measure>
          <title>Mortality</title>
          <description>the ratio of dead patients against the corresponding group population</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>the Onset of Respiratory Distress Syndrome</title>
        <description>the age when the patients presented with respiratory distress sydnrome</description>
        <time_frame>up to 1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Homozygous or Compound Heterozygous ABCA3 Mutations</title>
            <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated homozgyous or compound heterozygous ABCA3 mutations.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
          </group>
          <group group_id="O2">
            <title>Single ABCA3 Mutation</title>
            <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated single mutations.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
          </group>
          <group group_id="O3">
            <title>no ABCA3 Mutations</title>
            <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which exclude all gene mutations involving in the respiratory disease.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
          </group>
        </group_list>
        <measure>
          <title>the Onset of Respiratory Distress Syndrome</title>
          <description>the age when the patients presented with respiratory distress sydnrome</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.83" lower_limit="0.1" upper_limit="5"/>
                    <measurement group_id="O2" value="4.6" lower_limit="1" upper_limit="10"/>
                    <measurement group_id="O3" value="5.24" lower_limit="0.1" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>the Age of Developing Severe RDS Marked With Oxygenation Index of 16</title>
        <description>the age when the patients develop severe RDS,which is marked with an oxygenation index of 16</description>
        <time_frame>through study of completion, an average of 1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Homozygous or Compound Heterozygous ABCA3 Mutations</title>
            <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated homozgyous or compound heterozygous ABCA3 mutations.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
          </group>
          <group group_id="O2">
            <title>Single ABCA3 Mutation</title>
            <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated single mutations.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
          </group>
          <group group_id="O3">
            <title>no ABCA3 Mutations</title>
            <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which exclude all gene mutations involving in the respiratory disease.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
          </group>
        </group_list>
        <measure>
          <title>the Age of Developing Severe RDS Marked With Oxygenation Index of 16</title>
          <description>the age when the patients develop severe RDS,which is marked with an oxygenation index of 16</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.06" lower_limit="0.1" upper_limit="2"/>
                    <measurement group_id="O2" value="5.3" lower_limit="2" upper_limit="15"/>
                    <measurement group_id="O3" value="4.5" lower_limit="1" upper_limit="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Radiological Score</title>
        <description>The chest x-ray was rated in three sections on both sides of the lung: apex to the carina, carina to the lower pulmonary vein, and lower pulmonary vein to diaphragm. The incidence of radiological features, including ground-glass opacity, reticular pattern, air bronchogram, atelectasis, and air leak, was evaluated for each lung section, respectively. Each finding was scored as 0=none, 1=discrete，2=diffuse, and 3= strong at each section. An overall cumulative score was calculated by adding the individual section scores together, making a minimum of 0, and a maximum of 18 for each patient. Higher scores mean the higher severity of the radiological apperance, and commonly predict worse respiratory outcomes.</description>
        <time_frame>through study of completion, an average of 1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Homozygous or Compound Heterozygous ABCA3 Mutations</title>
            <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated homozgyous or compound heterozygous ABCA3 mutations.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
          </group>
          <group group_id="O2">
            <title>Single ABCA3 Mutation</title>
            <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated single mutations.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
          </group>
          <group group_id="O3">
            <title>no ABCA3 Mutations</title>
            <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which exclude all gene mutations involving in the respiratory disease.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
          </group>
        </group_list>
        <measure>
          <title>Radiological Score</title>
          <description>The chest x-ray was rated in three sections on both sides of the lung: apex to the carina, carina to the lower pulmonary vein, and lower pulmonary vein to diaphragm. The incidence of radiological features, including ground-glass opacity, reticular pattern, air bronchogram, atelectasis, and air leak, was evaluated for each lung section, respectively. Each finding was scored as 0=none, 1=discrete，2=diffuse, and 3= strong at each section. An overall cumulative score was calculated by adding the individual section scores together, making a minimum of 0, and a maximum of 18 for each patient. Higher scores mean the higher severity of the radiological apperance, and commonly predict worse respiratory outcomes.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ground glass opacity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.29" spread="1.38"/>
                    <measurement group_id="O2" value="12.90" spread="2.03"/>
                    <measurement group_id="O3" value="10.77" spread="1.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>reticular pattern</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.14" spread="1.22"/>
                    <measurement group_id="O2" value="14.90" spread="0.88"/>
                    <measurement group_id="O3" value="13.23" spread="2.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>air bronchogram</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.86" spread="2.34"/>
                    <measurement group_id="O2" value="11.00" spread="1.25"/>
                    <measurement group_id="O3" value="7.86" spread="3.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>atelectasis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.57" spread="2.82"/>
                    <measurement group_id="O2" value="3.20" spread="2.35"/>
                    <measurement group_id="O3" value="2.64" spread="0.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>air leakage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.43" spread="1.99"/>
                    <measurement group_id="O2" value="1.20" spread="1.40"/>
                    <measurement group_id="O3" value="0.91" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>cysts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.86" spread="2.04"/>
                    <measurement group_id="O2" value="1.00" spread="1.25"/>
                    <measurement group_id="O3" value="0.50" spread="0.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>through study completion, an average of 1 month</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Homozygous or Compound Heterozygous ABCA3 Mutations</title>
          <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated homozgyous or compound heterozygous ABCA3 mutations.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
        </group>
        <group group_id="E2">
          <title>Single ABCA3 Mutation</title>
          <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which indicated single mutations.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
        </group>
        <group group_id="E3">
          <title>no ABCA3 Mutations</title>
          <description>patients meet the criteria for fatal respiratory distress sydrome and undergone exome sequencing, which exclude all gene mutations involving in the respiratory disease.&#xD;
no intervention: there is no intervention in this study, only observation.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="22"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jianhui Wang</name_or_title>
      <organization>Children's Hospital of Chongqing Medical University</organization>
      <phone>13678428167</phone>
      <email>wangjh@cqmu.edu.cn</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

